Signaling by small GTPases in the immune system

Immunological Reviews

Volumn 218, Issue 1, 2007, Pages 92-101

  Scheele, Juergen S ^a,b   Marks, Reinhard E ^b   Boss, Gerry R ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

GTPase; Immunoregulation; Integrins; Quantitative biochemical assays; Ras family

Indexed keywords

GENE PRODUCT; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; INTERLEUKIN 2 RECEPTOR; LOW MOLECULAR WEIGHT PROTEIN; RAC PROTEIN; RAP1 PROTEIN; RAS PROTEIN; RHEB PROTEIN; RHO FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CHEMICAL ANALYSIS; CLONAL ANERGY; DENDRITIC CELL; GENE FUNCTION; HUMAN; IMMUNE SYSTEM; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; MONOMERIC GTP-BINDING PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 34447312705     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2007.00530.x     Document Type: Review

References (125)

1. Bos JL. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J 1998 17:6776 6782.
2. Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987 56:615 649.
3. Mochizuki N, et al. Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i). Nature 1999 400:891 894.
4. Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999 399:697 700.
5. Bottorff D, Ebinu J, Stone JC. RasGRP, a Ras activator: mouse and human cDNA sequences and chromosomal positions. Mamm Genome 1999 10:358 361.
6. Kawasaki H, et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci USA 1998 95:13278 13283.
7. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. Increasing complexity of Ras signaling. Oncogene 1998 17:1395 1413.
8. Macara IG, Lounsbury KM, Richards SA, McKiernan C, Bar-Sagi D. The Ras superfamily of GTPases. FASEB J 1996 10:625 630.
9. Valencia A, Chardin P, Wittinghofer A, Sander C. The ras protein family: evolutionary tree and role of conserved amino acids. Biochemistry 1991 30:4637 4648.
10. Wittinghofer A, Pai EF. The structure of Ras protein: a model for a universal molecular switch. Trends Biochem Sci 1991 16:382 387.
11. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature 1993 366:643 654.
12. Thomas SM, DeMarco M, D'Arcangelo G, Halegoua S, Brugge JS. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 1992 68:1031 1040.
13. Wood KW, Sarnecki C, Roberts TM, Blenis J. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 1992 68:1041 1050.
14. Leevers SJ, Marshall CJ. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J 1992 11:569 574.
15. Robbins DJ, Cheng M, Zhen E, Vanderbilt CA, Feig LA, Cobb MH. Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade. Proc Natl Acad Sci USA 1992 89:6924 6928.
16. Satoh T, Endo M, Nakafuko M, Nakamura S, Kaziro Y. Platelet-derived growth factor stimulates formation of active p21rasGTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci USA 1990 87:5993 5997.
17. Satoh T, Endo M, Nakafuko M, Akyama T, Yamamoto T, Kaziro Y. Accumulation of p21ras GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci USA 1990 87:7926 7929.
18. Atkinson DE. The energy charge of the adenylate pool as a regulatory parameter: interaction with feedback modifiers. Biochemistry 1968 7:4030 4034.
19. Brumm AF, Potter VR, Siekevitz P. Nucleotide metabolism V. Incorporation of P32 into acid-soluble nucleotides of rat liver in vivo. J Biol Chem 1956 220:713 722.
20. Nguyen BT, Sadée W. Compartmentation of guanine nucleotide precursors for DNA synthesis. Biochem J 1986 234:263 269.
21. De Rooij J, Bos JL. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 1997 14:623 625.
22. Scheele JS, Rhee JM, Boss GR. Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: comparison of parental and Ras-overproducing NIH 3T3 fibroblasts. Proc Natl Acad Sci USA 1995 92:1097 1100.
23. Sharma PM, et al. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J Biol Chem 1998 273:18528 18537.
24. von Lintig FC, Pilz RB, Boss GR. Quantitative determination of Rap 1 activation in cyclic nucleotide-treated HL-60 leukemic cells: lack of Rap 1 activation in variant cells. Oncogene 2000 19:4029 4034.
25. Im E, et al. Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells. Oncogene 2002 21:6356 6365.
26. Chen JC, Zhuang S, Nguyen TH, Boss GR, Pilz RB. Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. J Biol Chem 2003 278:2807 2818.
27. Prigent SA, et al. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated EGF receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem 1996 271:25639 25645.
28. Pilz RB, Huvar I, Scheele JS, Van den Berghe G, Boss GR. A decrease in the intracellular guanosine 5'-triphosphate concentration is necessary for granulocytic differentiation of HL-60 cells, but growth cessation and differentiation are not associated with a change in the activation state of Ras, the transforming principle of HL-60 cells. Cell Growth Differ 1997 8:53 59.
29. Gudi S, et al. Rapid activation of Ras by fluid flow is mediated by Gα and Gβγ subunits of heterotrimeric G proteins in human endothelial cells. Arterioscler Thromb Vasc Biol 2003 23:994 1000.
30. Khare S, et al. 1,25-Dihydroxyvitamin D3 but not TPA activates PLD in Caco-2 cells via pp60c-src and RhoA. Am J Physiol 1999 276:G1005 G1015.
31. Egawa K, et al. Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J Biol Chem 1999 274:14306 14314.
32. Tian W, Boss GR, Cohen DM. Ras signaling in the inner medullary cell response to urea and NaCl. Am J Physiol 2000 278:372 380.
33. Qiu W, Zhuang S, von Lintig FC, Boss GR, Pilz RB. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J Biol Chem 2000 275:31921 31929.
34. Dupuy AJ, et al. Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia. J Biol Chem 2001 276:11804 11811.
35. Gudi T, Chen JC, Casteel DE, Seasholtz TM, Boss GR., Pilz RB. cGMP-dependent protein kinase inhibits serum response element-dependent transcription by inhibiting Rho activation and functions. J Biol Chem 2002 277:37393 37382.
36. Bissonnette M, et al. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on MAPK, COX-1 and cyclin D1. Cancer Res 2000 60:4602 4609.
37. Khare S, et al. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Res 2003 63:3517 3523.
38. Liu M-L, et al. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice. Oncogene 1998 18:2403 2411.
39. Guha A, et al. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 1996 12:507 513.
40. Guha A, Feldkamp M, Lau N, Huvar I, Boss G, Pawson T. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 1997 15:2755 2765.
41. Lau N, et al. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression. Int J Oncol 2003 22:195 200.
42. von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. Ras activation in human breast cancer. Breast Cancer Res Treat 2000 62:51 62.
43. Cohen G, et al. Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci. Cancer Res 2006 66:5656 5664.
44. von Lintig FC, Huvar I, Law P, Diccianni MB, Yu AL, Boss GR. Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clin Cancer Res 2000 6:1804 1810.
45. Haugh JM, Huang AC, Wiley HS, Wells A, Lauffenburger DA. Internalized epidermal growth factor receptors participate in the activation of p21ras in fibroblasts. J Biol Chem 1999 274:34350 34360.
46. Feldkamp MM, Lala P, Lau N, Roncari L, Guha A. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery 1999 45:1442 1453.
47. Feldkamp MM, Angelov L, Guha A. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. Surg Neurol 1999 51:211 218.
48. Feldkamp MM, Lau N, Roncari L, Guha A. Isotype-specific Ras.GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status. Cancer Res 2001 61:4425 4431.
49. McCormick F. Signal transduction. How receptors turn Ras on. Nature 1993 363:15 16.
50. Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL, Crabtree GR. Signal transduction in T lymphocytes using a conditional allele of SOS. Proc Natl Acad Sci USA 1995 92:9810 9814.
51. Buday L, Egan SE, Rodriguez Viciana P, Cantrell DA, Downward J. A complex of Grb2 adaptor protein, SOS exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J Biol Chem 1994 269:9019 9023.
52. Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, Samelson LE. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling. J Biol Chem 2000 275:23355 23361.
53. Ebinu JO, et al. RasGRP links T-cell receptor signaling to Ras. Blood 2000 95:3199 3203.
54. Dower NA, et al. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol 2000 1:317 321.
55. Bivona TG, et al. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature 2003 424:694 698.
56. Gartner F, et al. Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion. Immunity 1999 10:537 546.
57. Swan KA, et al. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J 1995 14:276 285.
58. Fields PE, Gajewski TF, Fitch FW. Blocked Ras activation in anergic CD4+ T cells. Science 1996 271:1276 1278.
59. Genot E, Cleverley S, Henning S, Cantrell D. Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J 1996 15:3923 3933.
60. Izquierdo M, Leevers SJ, Marshall CJ, Cantrell D. p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J Exp Med 1993 178:1199 1208.
61. Iritani BM, Alberola-Ila J, Forbush KA, Perimutter RM. Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors. Immunity 1999 10:713 722.
62. Woodrow MA, Rayter S, Downward J., Cantrell DA. p21ras function is important for T cell antigen receptor and protein kinase C regulation of nuclear factor of activated T cells. J Immunol 1993 150:3853 3861.
63. Whitehurst CE, Geppert TD. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J Immunol 1996 156:1020 1029.
64. Rayter SI, Woodrow M, Lucas SC, Cantrell DA, Downward J. p21ras mediates control of IL-2 gene promoter function in T cell activation. EMBO J 1992 11:4549 4556.
65. Baldari CT, Heguy A, Telford JL. ras protein activity is essential for T-cell antigen receptor signal transduction. J Biol Chem 1993 268:2693 2698.
66. Boulet AM, Capecchi MR. Targeted disruption of hoxc-4 causes esophageal defects and vertebral transformations. Dev Biol 1996 177:232 249.
67. Genot E, Cantrell DA. Ras regulation and function in lymphocytes. Curr Opin Immunol 2000 12:289 294.
68. Satoh T, Nakafuku M, Miyajima A, Kaziro Y. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 1991 88:3314 3318.
69. Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA. The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes. J Immunol 1992 148:2417 2422.
70. Marks RE, Ho AW, Rivas F, Marshall E, Janardhan S, Gajewski TF. Differential Ras signaling via the antigen receptor and IL-2 receptor in primary T lymphocytes. Biochem Biophys Res Commun 2003 312:691 696.
71. Pastor MI, Woodrow M, Cantrell D. Regulation and function of p21ras in T lymphocytes. Cancer Surv 1995 22:75 83.
72. Zhu X, Suen KL, Barbacid M, Bolen JB, Fargnoli J. Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cell proliferation. J Biol Chem 1994 269:5518 5522.
73. Gomez J, Martinez AC, Fernandez B, Garcia A, Rebollo A. Critical role of Ras in the proliferation and prevention of apoptosis mediated by IL-2. J Immunol 1996 157:2272 2281.
74. Herrmann C, Horn G, Spaargaren M, Wittinghofer A. Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J Biol Chem 1996 271:6794 6800.
75. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S, Takai Y. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. J Biol Chem 1996 271:1258 1261.
76. Beranger F, Goud B, Tavitian A, de Gunzburg J. Association of the Ras-antagonistic Rap1/Krev-1 proteins with the Golgi complex. Proc Natl Acad Sci USA 1991 88:1606 1610.
77. Arai A, Nosaka Y, Kanda E, Yamamoto K, Miyasaka N, Miura O. Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta(1) integrin-mediated hematopoietic cell adhesion. J Biol Chem 2001 276:10453 10462.
78. Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat Immunol 2002 3:251 258.
79. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 1997 278:124 128.
80. Xing L, Ge C, Zeltser R, Maskevitch G, Mayer BJ, Alexandropoulos K. c-Src signaling induced by the adapters Sin and Cas is mediated by Rap1 GTPase. Mol Cell Biol 2000 20:7363 7377.
81. Peterson EJ, et al. Coupling of the TCR to integrin activation by SLAP-130/Fyb. Science 2001 293:2263 2265.
82. Griffiths EK, et al. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science 2001 293:2260 2263.
83. Ishida D, et al. Antigen-driven T cell anergy and defective memory T cell response via deregulated Rap1 activation in SPA-1-deficient mice. Proc Natl Acad Sci USA 2003 100:10919 10924.
84. Carey KD, et al. CD28 and the tyrosine kinase Lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1. Mol Cell Biol 2000 20:8409 8419.
85. Reedquist KA, Bos JL. Costimulation through CD28 suppresses T cell receptor-dependent activation of the ras-like small GTPase Rap1 in human T lymphocytes. J Biol Chem 1998 273:4944 4949.
86. York RD, et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 1998 392:622 626.
87. Bos JL, de Rooij J, Reedquist KA. Rap1 signaling: adhering to new models. Nat Rev Mol Cell Biol 2001 2:369 377.
88. Enserink JM, et al. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 2002 4:901 906.
89. Woods ML, Shimizu Y. Signaling networks regulating beta 1 integrin-mediated adhesion of T lymphocytes to extracellular matrix. J Leukoc Biol 2001 69:874 880.
90. Epler JA, Liu R, Chung H, Ottoson NC, Shimizu Y. Regulation of beta 1 integrin-mediated adhesion by T cell receptor signaling involves ZAP-70 but differs from signaling events that regulate transcriptional activity. J Immunol 2000 165:4941 4949.
91. Garrett WS, et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000 102:325 334.
92. Sugihara K, et al. Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 1998 17:3427 3433.
93. West MA, Prescott AR, Eskelinen EL, Ridley AJ, Watts C. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr Biol 2000 10:839 848.
94. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002 2:151 161.
95. Iyoda T, et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002 195:1289 1302.
96. den Haan JM, Lehar SM, Bevan MJ. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000 192:1685 1696.
97. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001 19:47 64.
98. Mosmann TR, Bond MW, Coffman RL, Ohara J, Paul WE. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc Natl Acad Sci USA 1986 83:5654 5658.
99. Fitch FW. The good old days - past, present, and future. J Immunol 1993 151:1747 1756.
100. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989 7:145 173.
101. Allison JP. CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994 6:414 419.
102. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993 11:191 212.
103. Cantrell DA. T-cell antigen receptor signal transduction. Immunology 2002 105:369 374.
104. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998 92:83 92.
105. Koretzky GA, Myung PS. Positive and negative regulation of T-cell activation by adaptor proteins. Nat Rev Immunol 2001 1:95 107.
106. Crabtree GR. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 1999 96:611 614.
107. Kuo CT, Leiden JM. Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 1999 17:149 187.
108. Matthews SA, Rozengurt E, Cantrell D. Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J Exp Med 2000 191:2075 2082.
109. Tognon CE, Kirk HE, Passmore LA, Whitehead IP, Der CJ, Kay RJ. Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol 1998 18:6995 7008.
110. Jones RG, et al. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med 2000 191:1721 1734.
111. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000 346:561 576.
112. Scharenberg AM, Kinet JP. PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell 1998 94:5 8.
113. Gesbert F, Delespine-Carmagnat M, Bertoglio J. Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol 1998 18:307 320.
114. Malek TR, Yu A, Scibelli P, Lichtenheld MG, Codias EK. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J Immunol 2001 166:1675 1683.
115. Johnston JA, et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 1994 370:151 153.
116. Witthuhn BA, et al. Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 1994 370:153 157.
117. Lin JX, Leonard WJ. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 2000 19:2566 2576.
118. Reif K, Burgering BM, Cantrell DA. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J Biol Chem 1997 272:14426 14433.
119. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 1996 15:5256 5267.
120. Mapara MY, Sykes M. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J Clin Oncol 2004 22:1136 1151.
121. Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. J Mol Med 2001 78:673 683.
122. Shimonaka M, et al. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol 2003 161:417 427.
123. Kinashi T, et al. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood 2004 103:1033 1036.
124. Wakamatsu N, et al. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet 2001 27:369 370.
125. Reedquist KA, et al. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol 2000 148:1151 1158.